These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6728869)

  • 41. Clozapine decreases neuropeptide Y-like immunoreactivity and neuropeptide Y mRNA levels in rat nucleus accumbens.
    Obuchowicz E; Turchan J
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):329-35. PubMed ID: 10422894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC; Davis JM
    Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
    [No Abstract]   [Full Text] [Related]  

  • 43. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
    Maidment NT; Marsden CA
    Eur J Pharmacol; 1987 Apr; 136(2):141-9. PubMed ID: 3595718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex.
    Godbout R; Mantz J; Glowinski J; Thierry AM
    Eur J Pharmacol; 1991 Oct; 204(1):97-100. PubMed ID: 1666564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
    Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
    Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
    De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat.
    Eliasson M; Meyerson BJ
    Psychopharmacology (Berl); 1976 Sep; 49(3):301-6. PubMed ID: 826947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Locomotor activity and the nucleus accumbens].
    Morgenstern R; Gold R; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):947-53. PubMed ID: 6651811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects.
    Lappalainen J; Hietala J; Koulu M; Syvälahti E
    Eur J Pharmacol; 1990 Nov; 190(3):403-7. PubMed ID: 2125564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum.
    Racagni G; Cheney DL; Trabucchi M; Costa E
    J Pharmacol Exp Ther; 1976 Feb; 196(2):323-32. PubMed ID: 943521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of thioridazine, clozapine and metoclopramide on the induction of adrenomedullary enzymes by apomorphine.
    Ekker M; Sourkes TL
    Neuropharmacology; 1985 Nov; 24(11):1063-6. PubMed ID: 2867484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Actions of repeated injections of LSD and apomorphine on the copulatory response of female rats.
    Eliasson M
    Pharmacol Biochem Behav; 1976 Dec; 5(6):621-5. PubMed ID: 1023230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism.
    Ferré S; Artigas F
    Neurosci Lett; 1995 Feb; 187(1):61-4. PubMed ID: 7617304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis.
    Chai B; Meltzer HY
    Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo.
    Navailles S; De Deurwaerdère P; Spampinato U
    Biol Psychiatry; 2006 Mar; 59(6):568-75. PubMed ID: 16182256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1994 Sep; 49(1):115-20. PubMed ID: 7816860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen.
    Chen J; Paredes W; van Praag HM; Gardner EL
    Brain Res; 1992 Jun; 582(1):173-9. PubMed ID: 1379872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.